News

Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue ...
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...
The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...
Cigna on Wednesday said it negotiated with Novo Nordisk and Eli Lilly to secure deeper GLP-1 drug discounts for employers ...
The focus of the lawsuit is forfeited funds, which total the amount of employer match contributions participants lose if they ...
The health insurer is accused of using forfeited funds from departing employees to reduce employer contributions to the ...
Investing.com -- Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss ...
The stock's fall snapped a five-day winning streak.